Abstract
Restricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.Programmed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 782-789 |
| Number of pages | 8 |
| Journal | European Urology |
| Volume | 76 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2019 |
Keywords
- Bladder cancer
- Immune checkpoint blockade
- Meta-analysis
- Programmed death ligand-1 blockade
- Programmed death-1 blockade
- Urothelial cancer
Fingerprint
Dive into the research topics of 'Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis(Figure presented.)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver